These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9555661)

  • 41. The effects of functional suppression of a membrane-bound complement regulatory protein, CD59, in the synovial tissue in rats.
    Mizuno M; Nishikawa K; Goodfellow RM; Piddlesden SJ; Morgan BP; Matsuo S
    Arthritis Rheum; 1997 Mar; 40(3):527-33. PubMed ID: 9082941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis.
    Heeringa P; van Goor H; Itoh-Lindstrom Y; Maeda N; Falk RJ; Assmann KJ; Kallenberg CG; Jennette JC
    Am J Pathol; 2000 Mar; 156(3):879-88. PubMed ID: 10702405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis.
    Mauer SM; Sutherland DE; Howard RJ; Fish AJ; Najarian JS; Michael AF
    J Exp Med; 1973 Mar; 137(3):553-70. PubMed ID: 4570015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A complement-dependent model of thrombotic thrombocytopenic purpura induced by antibodies reactive with endothelial cells.
    Ren G; Hack BK; Minto AW; Cunningham PN; Alexander JJ; Haas M; Quigg RJ
    Clin Immunol; 2002 Apr; 103(1):43-53. PubMed ID: 11987984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble CD59 expressed from an adenovirus in vivo is a potent inhibitor of complement deposition on murine liver vascular endothelium.
    Gandhi J; Cashman SM; Kumar-Singh R
    PLoS One; 2011; 6(6):e21621. PubMed ID: 21720565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Further studies on the biologic properties of guinea pig IgG1 antibodies. II. In vivo activation of C3 by anti-glomerular basement membrane antibodies.
    Vuagnat P
    J Immunol; 1975 Sep; 115(3):787-95. PubMed ID: 50374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenesis of glomerular damage in glomerulonephritis.
    Couser WG
    Nephrol Dial Transplant; 1998; 13 Suppl 1():10-5. PubMed ID: 9507491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
    Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
    J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).
    Jansen JH; Høgåsen K; Mollnes TE
    Am J Pathol; 1993 Nov; 143(5):1356-65. PubMed ID: 8238252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
    Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
    Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.
    Yao X; Verkman AS
    Acta Neuropathol Commun; 2017 Jul; 5(1):57. PubMed ID: 28750658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelets mediate neutrophil-dependent immune complex nephritis in the rat.
    Johnson RJ; Alpers CE; Pritzl P; Schulze M; Baker P; Pruchno C; Couser WG
    J Clin Invest; 1988 Oct; 82(4):1225-35. PubMed ID: 2971672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bortezomib-induced glomerular microangiopathy complicated with monoclonal immunoglobulin deposition disease.
    Mizuno S; Kitayama C; Sanada S; Sato T
    CEN Case Rep; 2021 Nov; 10(4):537-542. PubMed ID: 33909224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
    Yamada K; Miwa T; Liu J; Nangaku M; Song WC
    J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells.
    Rooney IA; Davies A; Griffiths D; Williams JD; Davies M; Meri S; Lachmann PJ; Morgan BP
    Clin Exp Immunol; 1991 Feb; 83(2):251-6. PubMed ID: 1704296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
    Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
    J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury.
    Yamada K; Hori Y; Hanafusa N; Okuda T; Nagano N; Choi-Miura NH; Couser WG; Miyata T; Kurokawa K; Fujita T; Nangaku M
    Kidney Int; 2001 Jan; 59(1):137-46. PubMed ID: 11135066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis.
    Brooimans RA; Van der Ark AA; Tomita M; Van Es LA; Daha MR
    Eur J Immunol; 1992 Mar; 22(3):791-7. PubMed ID: 1372260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy.
    Nangaku M; Pippin J; Richardson CA; Schulze M; Young BA; Alpers CE; Gordon KL; Johnson RJ; Couser WG
    Kidney Int; 1996 Dec; 50(6):2054-62. PubMed ID: 8943490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA; Sims PJ
    J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.